Back to Authors

Ferreira, Lino

0000-0001-8985-9302

Mayo Clinic

CNC - Center for Neurosciences and Cell Biology, University of Coimbra, Rua Larga Edificio FMUC Piso 1, 3004-504 Coimbra, Portugal.

Citations 2

Pharmacological clearance of senescent cells reduces inflammation, endothelial damage and cardiac fibrosis in HFpEF
Silva, Elsa D. , Tomé, Inês , Vasques-Nóvoa, Francisco, Santos-Ribeiro, Diana , Angélico‐Gonçalves, António , Adão, Rui , Caetano, Carolina , Kirkland, James L. , Ferreira, Lino , Santos-Ribeiro, Diana , Adão, Rui , Tchkonia, Tamara, Ferreira, Lino , Vasques‐Nóvoa, Francisco , Conceição, Glória , Silva, Andreia , Barros, António Sousa , Mendes‐Ferreira, Pedro , Gonçalves, Alexandre, Pereira-Sousa, Daniel , Miranda‐Silva, Daniela , Juni, Rio P. , Tchkonia, Tamar , Caramelo, Francisco José , Gonçalves, Nádia Pereira , Sampaio‐Pinto, Vasco , Ribeiro, João S, Boon, Reinier Abraham , Leite-Moreira, Adelino Ferreira , Pitrez, Patrícia R. , Pinto‐do‐Ó, Perpétua , Santos, Susana Gomes , Falcão‐Pires, Inês

Cardiovascular Research | October 30, 2025 | Volume: 121 | Issue: 15 | Pages: 2385-2403

10.1093/cvr/cvaf208 Get It

Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is one of the most common forms of heart failure with no effective treatment. While chronic systemic inflammation, triggered by comorbidities, is a critical factor of HFpEF pathophysiology and a relevant target for therapy, mechanisms underlying inflammation remain poorly understood. Here, we aim to understand the upstream mechanisms driving inflammation, including immune dysregulation and cellular senescence. Methods and results ZSF1-Obese rats, a cardiometabolic model of HFpEF, were used to investigate systemic and cardiac inflammation, and to characterise the senescent program in immune, circulating endothelial and cardiac cells, before disease onset and onward. Using patient samples, we further evaluated the association between cellular senescence and diagnostic and prognostic markers of HFpEF. Finally, we administered a senolytic - Navitoclax - at two time-points, before and after the appearance of HFpEF. Conclusion ZSF1-Obese rats had increased immune and endothelial senescent cells in their peripheral blood and myocardium, together with exacerbated systemic inflammation and endothelial damage, compared to control ZSF1-Lean rats. Moreover, increased circulating senescent leucocytes were associated with markers of disease severity in patients with HFpEF. Senescent cell clearance decreased circulating B-type natriuretic peptide levels and attenuated inflammation, vascular remodelling, and cardiac fibrosis. Additionally, it improved renal function and reduced pulmonary oedema. Our findings suggest that senotherapeutics may improve the treatment for HFpEF by attenuating systemic effects of the disease whilst reducing cardiac fibrosis and endothelial rarefaction.
Blood–brain barrier dysfunction in aging is mediated by brain endothelial senescence
Novo, João P. , Gee, Lucy, Caetano, Carolina A., Tomé, Inês , Vilaça, Andreia , Jurk, Diana , Rosa, Susana , Ferreira, Lino , Caetano, Carolina , Jurk, Diana , Ferreira, Lino , Zglinicki, Thomas von , Moreira, Irina Sousa

Aging Cell | August 15, 2024 | Volume: 23 | Issue: 9 | Pages: No page available

10.1111/acel.14270 Get It

AbstractBBB dysfunction during aging is characterized by an increase in its permeability and phenotypic alterations of brain endothelial cells (BECs) including dysregulation of tight junction's expression. Here we have investigated the role of BEC senescence in the dysfunction of the BBB. Our results suggest that the transition from young to aged BBB is mediated, at least in part by BEC senescence.